Differential Expression Analysis
EPOCH / P Comparison
Note: The Fold Change value for up-regulated genes is displayed in red; down-regulated values are displayed in blue.
Gene | Annotation | pval | Fold Change (log2ratio) |
---|---|---|---|
mc2r | melanocortin 2 receptor | 7.797e-10 | 6.927e+0 |
npy | neuropeptide Y | 1.752e-5 | 6.116e+0 |
col5a2 | collagen, type V, alpha 2 | 6.200e-4 | 5.243e+0 |
2610034m16rik | RIKEN cDNA 2610034M16 gene | 3.182e-5 | 4.946e+0 |
tmco2 | transmembrane and coiled-coil domains 2 | 7.075e-8 | 4.872e+0 |
prnp | prion protein | 6.699e-7 | 4.742e+0 |
tcrg-v3 | T-cell receptor gamma, variable 3 | 2.453e-4 | 4.653e+0 |
hemgn | hemogen | 2.494e-5 | 4.336e+0 |
slamf1 | signaling lymphocytic activation molecule family member 1 | 1.023e-6 | 4.299e+0 |
ccnb1ip1 | cyclin B1 interacting protein 1 | 1.691e-5 | 4.244e+0 |
rims1 | regulating synaptic membrane exocytosis 1 | 2.099e-7 | 4.204e+0 |
zfpm2 | zinc finger protein, multitype 2 | 4.176e-7 | 4.198e+0 |
mest | mesoderm specific transcript | 7.636e-3 | 4.058e+0 |
9530019h20rik | RIKEN cDNA 9530019H20 gene | 2.559e-5 | 4.040e+0 |
pgm5 | phosphoglucomutase 5 | 9.003e-8 | 3.975e+0 |
irs1 | insulin receptor substrate 1 | 7.590e-5 | 3.954e+0 |
rgs8 | regulator of G-protein signaling 8 | 1.022e-6 | 3.948e+0 |
2310076g05rik | RIKEN cDNA 2310076G05 gene | 1.430e-6 | 3.879e+0 |
mapk4 | mitogen-activated protein kinase 4 | 8.930e-8 | 3.877e+0 |
rapsn | receptor-associated protein of the synapse | 9.740e-6 | 3.876e+0 |
2810432l12rik | RIKEN cDNA 2810432L12 gene | 4.503e-6 | 3.800e+0 |
cntn3 | contactin 3 | 9.984e-6 | 3.796e+0 |
cst7 | cystatin F (leukocystatin) | 1.642e-4 | 3.784e+0 |
obscn | obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | 5.945e-5 | 3.758e+0 |
reep1 | receptor accessory protein 1 | 7.520e-5 | 3.731e+0 |
insc | inscuteable homolog (Drosophila) | 6.889e-7 | 3.564e+0 |
c77097 | expressed sequence C77097 | 1.953e-6 | 3.492e+0 |
pf4 | platelet factor 4 | 1.966e-2 | 3.491e+0 |
a830059i20rik | RIKEN cDNA A830059I20 gene | 1.824e-5 | 3.385e+0 |
bc023969 | cDNA sequence BC023969 | 4.608e-5 | 3.302e+0 |
ppp1r14c | protein phosphatase 1, regulatory (inhibitor) subunit 14c | 5.717e-7 | 3.297e+0 |
4833414e09rik | RIKEN cDNA 4833414E09 gene | 5.832e-6 | 3.256e+0 |
cth | cystathionase (cystathionine gamma-lyase) | 1.263e-5 | 3.250e+0 |
vstm2a | V-set and transmembrane domain containing 2A | 3.346e-4 | 3.243e+0 |
gzmb | granzyme B | 1.447e-4 | 3.215e+0 |
idi1 | isopentenyl-diphosphate delta isomerase | 1.429e-5 | 3.191e+0 |
1810073o08rik | RIKEN cDNA 1810073O08 gene | 4.095e-4 | 3.186e+0 |
st8sia6 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 | 1.270e-5 | 3.147e+0 |
a930003a15rik | RIKEN cDNA A930003A15 gene | 1.343e-4 | 3.124e+0 |
1190002f15rik | RIKEN cDNA 1190002F15 gene | 1.027e-5 | 3.105e+0 |
9130213b05rik | RIKEN cDNA 9130213B05 gene | 4.044e-4 | 3.094e+0 |
socs2 | suppressor of cytokine signaling 2 | 1.026e-6 | 3.092e+0 |
ottmusg00000015529 | predicted gene, OTTMUSG00000015529 | 4.984e-3 | 3.088e+0 |
ai449310 | expressed sequence AI449310 | 2.328e-3 | 3.054e+0 |
mycn | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 1.478e-8 | 3.025e+0 |
hacl1 | 2-hydroxyacyl-CoA lyase 1 | 7.918e-5 | 3.015e+0 |
actr3b | ARP3 actin-related protein 3 homolog B (yeast) | 1.895e-5 | 2.995e+0 |
upp1 | uridine phosphorylase 1 | 1.299e-3 | 2.968e+0 |
6030498e09rik | RIKEN cDNA 6030498E09 gene | 1.342e-3 | 2.967e+0 |
gstt3 | glutathione S-transferase, theta 3 | 7.172e-6 | 2.965e+0 |
prr16 | proline rich 16 | 1.033e-6 | 2.964e+0 |
cd244 | CD244 natural killer cell receptor 2B4 | 2.670e-4 | 2.958e+0 |
cyp26b1 | cytochrome P450, family 26, subfamily b, polypeptide 1 | 8.366e-7 | 2.950e+0 |
lrrn3 | leucine rich repeat protein 3, neuronal | 4.378e-6 | 2.937e+0 |
gypa | glycophorin A | 3.262e-4 | 2.933e+0 |
dkk1 | dickkopf homolog 1 (Xenopus laevis) | 6.787e-7 | 2.906e+0 |
nuak1 | NUAK family, SNF1-like kinase, 1 | 1.117e-3 | 2.886e+0 |
s100a1 | S100 calcium binding protein A1 | 1.528e-4 | 2.863e+0 |
9230114k14rik | RIKEN cDNA 9230114K14 gene | 3.573e-5 | 2.857e+0 |
pafah2 | platelet-activating factor acetylhydrolase 2 | 1.382e-5 | 2.844e+0 |
5330403d14rik | RIKEN cDNA 5330403D14 gene | 2.678e-5 | 2.835e+0 |
sema3a | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A | 9.975e-9 | 2.832e+0 |
gchfr | GTP cyclohydrolase I feedback regulator | 4.612e-5 | 2.831e+0 |
clic6 | chloride intracellular channel 6 | 4.411e-7 | 2.831e+0 |
2310050p20rik | RIKEN cDNA 2310050P20 gene | 4.367e-3 | 2.806e+0 |
phlda3 | pleckstrin homology-like domain, family A, member 3 | 1.420e-4 | 2.786e+0 |
ccdc25 | coiled-coil domain containing 25 | 1.223e-4 | 2.777e+0 |
shisa2 | shisa homolog 2 (Xenopus laevis) | 1.429e-3 | 2.768e+0 |
elavl2 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) | 4.381e-5 | 2.751e+0 |
akr1c13 | aldo-keto reductase family 1, member C13 | 1.082e-3 | 2.743e+0 |
selm | selenoprotein M | 2.286e-3 | 2.737e+0 |
8030447m02rik | RIKEN cDNA 8030447M02 gene | 2.334e-3 | 2.731e+0 |
dhrs3 | dehydrogenase/reductase (SDR family) member 3 | 5.444e-3 | 2.731e+0 |
sla2 | Src-like-adaptor 2 | 6.049e-5 | 2.718e+0 |
eya4 | eyes absent 4 homolog (Drosophila) | 3.835e-5 | 2.709e+0 |
serpina3g | serine (or cysteine) peptidase inhibitor, clade A, member 3G | 4.892e-5 | 2.707e+0 |
rab38 | Rab38, member of RAS oncogene family | 1.462e-4 | 2.702e+0 |
treml1 | triggering receptor expressed on myeloid cells-like 1 | 6.797e-5 | 2.698e+0 |
gm944 | gene model 944, (NCBI) | 1.792e-5 | 2.683e+0 |
gm1964 | gene model 1964, (NCBI) | 1.591e-4 | 2.662e+0 |
dbc1 | deleted in bladder cancer 1 (human) | 7.644e-7 | 2.631e+0 |
nov | nephroblastoma overexpressed gene | 3.135e-4 | 2.618e+0 |
rasl11a | RAS-like, family 11, member A | 4.275e-4 | 2.615e+0 |
lrrn4 | leucine rich repeat neuronal 4 | 3.225e-5 | 2.602e+0 |
f2rl2 | coagulation factor II (thrombin) receptor-like 2 | 7.120e-5 | 2.600e+0 |
samd14 | sterile alpha motif domain containing 14 | 1.649e-5 | 2.586e+0 |
ehd3 | EH-domain containing 3 | 1.241e-5 | 2.578e+0 |
5830405n20rik | RIKEN cDNA 5830405N20 gene | 9.997e-5 | 2.578e+0 |
prss16 | protease, serine, 16 (thymus) | 2.094e-5 | 2.561e+0 |
dbp | D site albumin promoter binding protein | 5.581e-6 | 2.559e+0 |
arl4a | ADP-ribosylation factor-like 4A | 5.903e-6 | 2.546e+0 |
exoc6b | exocyst complex component 6B | 7.702e-7 | 2.510e+0 |
gng11 | guanine nucleotide binding protein (G protein), gamma 11 | 1.288e-5 | 2.508e+0 |
p2ry10 | purinergic receptor P2Y, G-protein coupled 10 | 5.689e-3 | 2.506e+0 |
tal1 | T-cell acute lymphocytic leukemia 1 | 1.546e-5 | 2.489e+0 |
serpine2 | serine (or cysteine) peptidase inhibitor, clade E, member 2 | 4.395e-2 | 2.482e+0 |
pim2 | proviral integration site 2 | 5.062e-5 | 2.479e+0 |
mrvi1 | MRV integration site 1 | 3.772e-3 | 2.476e+0 |
stxbp6 | syntaxin binding protein 6 (amisyn) | 5.132e-6 | 2.453e+0 |
gfi1b | growth factor independent 1B | 7.962e-7 | 2.449e+0 |
ap1s3 | adaptor-related protein complex AP-1, sigma 3 | 1.057e-5 | 2.443e+0 |
tmem87a | transmembrane protein 87A | 4.453e-5 | 2.440e+0 |
2610016c23rik | RIKEN cDNA 2610016C23 gene | 7.345e-4 | 2.429e+0 |
slc7a8 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 8 | 1.338e-3 | 2.420e+0 |
ngly1 | N-glycanase 1 | 5.036e-4 | 2.419e+0 |
darc | Duffy blood group, chemokine receptor | 2.792e-5 | 2.413e+0 |
zmat3 | zinc finger matrin type 3 | 6.371e-5 | 2.411e+0 |
trpc6 | transient receptor potential cation channel, subfamily C, member 6 | 3.823e-3 | 2.409e+0 |
ai117581 | expressed sequence AI117581 | 2.628e-3 | 2.397e+0 |
bcat2 | branched chain aminotransferase 2, mitochondrial | 2.103e-5 | 2.396e+0 |
csgalnact1 | chondroitin sulfate N-acetylgalactosaminyltransferase 1 | 4.029e-4 | 2.386e+0 |
lss | lanosterol synthase | 3.674e-5 | 2.381e+0 |
tm7sf2 | transmembrane 7 superfamily member 2 | 7.239e-5 | 2.372e+0 |
rab27b | RAB27b, member RAS oncogene family | 1.114e-5 | 2.366e+0 |
c86595 | expressed sequence C86595 | 2.346e-2 | 2.353e+0 |
bcmo1 | beta-carotene 15,15'-monooxygenase | 2.276e-5 | 2.348e+0 |
hdgfrp3 | hepatoma-derived growth factor, related protein 3 | 1.011e-5 | 2.348e+0 |
nlrp10 | NLR family, pyrin domain containing 10 | 7.206e-4 | 2.336e+0 |
rbpms2 | RNA binding protein with multiple splicing 2 | 7.269e-5 | 2.318e+0 |
slc14a1 | solute carrier family 14 (urea transporter), member 1 | 6.613e-3 | 2.301e+0 |
depdc1b | DEP domain containing 1B | 4.392e-5 | 2.300e+0 |
akap2 | A kinase (PRKA) anchor protein 2 | 1.756e-2 | 2.299e+0 |
5430407p10rik | RIKEN cDNA 5430407P10 gene | 3.434e-5 | 2.292e+0 |
lancl3 | LanC lantibiotic synthetase component C-like 3 (bacterial) | 1.759e-3 | 2.287e+0 |
ai956758 | expressed sequence AI956758 | 1.206e-3 | 2.278e+0 |
a930026b05rik | RIKEN cDNA A930026B05 gene | 4.514e-5 | 2.271e+0 |
gstt1 | glutathione S-transferase, theta 1 | 1.286e-6 | 2.269e+0 |
sgip1 | SH3-domain GRB2-like (endophilin) interacting protein 1 | 6.231e-6 | 2.263e+0 |
usp40 | ubiquitin specific peptidase 40 | 1.428e-5 | 2.257e+0 |
8030474k03rik | RIKEN cDNA 8030474K03 gene | 7.329e-4 | 2.256e+0 |
tcrg-v4 | T-cell receptor gamma, variable 4 | 6.154e-4 | 2.255e+0 |
lyl1 | lymphoblastomic leukemia 1 | 1.065e-4 | 2.236e+0 |
macrod1 | MACRO domain containing 1 | 2.682e-5 | 2.229e+0 |
limch1 | LIM and calponin homology domains 1 | 6.899e-7 | 2.222e+0 |
loc621549 | hypothetical protein LOC621549 | 1.031e-5 | 2.220e+0 |
lgals9 | lectin, galactose binding, soluble 9 | 2.917e-4 | 2.217e+0 |
glyat | glycine-N-acyltransferase | 6.952e-8 | 2.197e+0 |
a530088e08rik | RIKEN cDNA A530088E08 gene | 3.168e-5 | 2.192e+0 |
aa407881 | expressed sequence AA407881 | 7.048e-4 | 2.187e+0 |
esco2 | establishment of cohesion 1 homolog 2 (S. cerevisiae) | 2.739e-4 | 2.171e+0 |
eg434402 | predicted gene, EG434402 | 4.593e-3 | 2.168e+0 |
csrp1 | cysteine and glycine-rich protein 1 | 1.631e-3 | 2.168e+0 |
armcx1 | armadillo repeat containing, X-linked 1 | 2.487e-3 | 2.162e+0 |
pcyt1b | phosphate cytidylyltransferase 1, choline, beta isoform | 4.403e-6 | 2.162e+0 |
a130009i22rik | RIKEN cDNA A130009I22 gene | 5.618e-4 | 2.156e+0 |
akr1c12 | aldo-keto reductase family 1, member C12 | 2.147e-3 | 2.156e+0 |
dcpp3 | demilune cell and parotid protein 3 | 6.534e-5 | 2.155e+0 |
h60a | histocompatibility 60a | 2.890e-7 | 2.153e+0 |
d10ertd709e | DNA segment, Chr 10, ERATO Doi 709, expressed | 8.365e-3 | 2.152e+0 |
kynu | kynureninase (L-kynurenine hydrolase) | 4.334e-4 | 2.148e+0 |
flt3l | FMS-like tyrosine kinase 3 ligand | 9.831e-5 | 2.147e+0 |
lat | linker for activation of T cells | 3.706e-4 | 2.142e+0 |
hddc3 | HD domain containing 3 | 3.507e-5 | 2.132e+0 |
cd48 | CD48 antigen | 2.766e-3 | 2.130e+0 |
pon3 | paraoxonase 3 | 1.013e-2 | 2.126e+0 |
g6pc3 | glucose 6 phosphatase, catalytic, 3 | 9.210e-5 | 2.119e+0 |
nat2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | 1.964e-3 | 2.097e+0 |
cyp4f16 | cytochrome P450, family 4, subfamily f, polypeptide 16 | 4.355e-3 | 2.097e+0 |
adat2 | adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae) | 5.310e-4 | 2.096e+0 |
cap2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | 2.394e-4 | 2.095e+0 |
scd2 | stearoyl-Coenzyme A desaturase 2 | 2.073e-5 | 2.082e+0 |
hexim2 | hexamthylene bis-acetamide inducible 2 | 3.998e-6 | 2.081e+0 |
rnd2 | Rho family GTPase 2 | 5.774e-3 | 2.051e+0 |
snurf | SNRPN upstream reading frame | 1.240e-2 | 2.044e+0 |
matn4 | matrilin 4 | 1.149e-6 | 2.040e+0 |
3110009e22rik | RIKEN cDNA 3110009E22 gene | 1.467e-4 | 2.034e+0 |
pde8a | phosphodiesterase 8A | 9.220e-4 | 2.027e+0 |
rwdd3 | RWD domain containing 3 | 1.514e-3 | 2.027e+0 |
f2rl3 | coagulation factor II (thrombin) receptor-like 3 | 5.488e-3 | 2.026e+0 |
zadh2 | zinc binding alcohol dehydrogenase, domain containing 2 | 5.550e-7 | 2.022e+0 |
deb1 | differentially expressed in B16F10 1 | 8.853e-5 | 2.008e+0 |
nefl | neurofilament, light polypeptide | 1.857e-5 | 2.007e+0 |
plscr4 | phospholipid scramblase 4 | 4.683e-5 | 2.007e+0 |
100042970 | predicted gene, 100042970 | 5.696e-5 | 2.006e+0 |
lrrc34 | leucine rich repeat containing 34 | 1.036e-3 | -2.003e+0 |
rgl1 | ral guanine nucleotide dissociation stimulator,-like 1 | 1.518e-2 | -2.005e+0 |
flt1 | FMS-like tyrosine kinase 1 | 1.508e-2 | -2.007e+0 |
1700029i01rik | RIKEN cDNA 1700029I01 gene | 1.037e-4 | -2.008e+0 |
adssl1 | adenylosuccinate synthetase like 1 | 2.363e-3 | -2.013e+0 |
cebpa | CCAAT/enhancer binding protein (C/EBP), alpha | 1.689e-2 | -2.014e+0 |
stab1 | stabilin 1 | 3.369e-2 | -2.015e+0 |
rabl2a | RAB, member of RAS oncogene family-like 2A | 2.743e-4 | -2.016e+0 |
arhgef3 | Rho guanine nucleotide exchange factor (GEF) 3 | 1.315e-3 | -2.025e+0 |
3021401c12rik | RIKEN cDNA 3021401C12 gene | 3.279e-2 | -2.026e+0 |
d12ertd553e | DNA segment, Chr 12, ERATO Doi 553, expressed | 2.851e-5 | -2.029e+0 |
ensmusg00000073981 | predicted gene, ENSMUSG00000073981 | 9.239e-3 | -2.032e+0 |
msrb3 | methionine sulfoxide reductase B3 | 1.392e-4 | -2.032e+0 |
dpp4 | dipeptidylpeptidase 4 | 1.931e-5 | -2.033e+0 |
ensmusg00000057924 | predicted gene, ENSMUSG00000057924 | 3.172e-4 | -2.034e+0 |
plcxd2 | phosphatidylinositol-specific phospholipase C, X domain containing 2 | 1.359e-3 | -2.035e+0 |
ptgir | prostaglandin I receptor (IP) | 9.259e-4 | -2.035e+0 |
sestd1 | SEC14 and spectrin domains 1 | 4.044e-3 | -2.037e+0 |
ednrb | endothelin receptor type B | 1.232e-3 | -2.038e+0 |
kel | Kell blood group | 4.006e-5 | -2.040e+0 |
il15 | interleukin 15 | 2.379e-2 | -2.046e+0 |
emp1 | epithelial membrane protein 1 | 2.774e-3 | -2.049e+0 |
cds1 | CDP-diacylglycerol synthase 1 | 9.567e-6 | -2.050e+0 |
kdr | kinase insert domain protein receptor | 3.016e-2 | -2.050e+0 |
gpr183 | G protein-coupled receptor 183 | 4.091e-3 | -2.051e+0 |
hmgn3 | high mobility group nucleosomal binding domain 3 | 4.319e-3 | -2.053e+0 |
xlr | X-linked lymphocyte-regulated complex | 6.706e-3 | -2.057e+0 |
usp10 | ubiquitin specific peptidase 10 | 6.854e-5 | -2.061e+0 |
gadd45g | growth arrest and DNA-damage-inducible 45 gamma | 1.071e-2 | -2.064e+0 |
st8sia1 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 | 1.086e-3 | -2.065e+0 |
rasgef1b | RasGEF domain family, member 1B | 3.051e-3 | -2.066e+0 |
mtap7d1 | microtubule-associated protein 7 domain containing 1 | 3.693e-4 | -2.066e+0 |
dusp8 | dual specificity phosphatase 8 | 1.083e-4 | -2.068e+0 |
id3 | inhibitor of DNA binding 3 | 1.556e-3 | -2.071e+0 |
eg626058 | predicted gene, EG626058 | 6.840e-3 | -2.074e+0 |
zfp36l1 | zinc finger protein 36, C3H type-like 1 | 7.489e-4 | -2.074e+0 |
2310058n22rik | RIKEN cDNA 2310058N22 gene | 1.423e-2 | -2.078e+0 |
tmem50b | transmembrane protein 50B | 1.153e-4 | -2.082e+0 |
mitf | microphthalmia-associated transcription factor | 1.068e-2 | -2.085e+0 |
gm885 | gene model 885, (NCBI) | 4.683e-3 | -2.089e+0 |
snx18 | sorting nexin 18 | 1.382e-4 | -2.091e+0 |
fbxo11 | F-box protein 11 | 2.860e-4 | -2.091e+0 |
rgs2 | regulator of G-protein signaling 2 | 7.123e-5 | -2.092e+0 |
bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 6.877e-4 | -2.093e+0 |
nid2 | nidogen 2 | 3.769e-2 | -2.093e+0 |
ptprf | protein tyrosine phosphatase, receptor type, F | 8.444e-3 | -2.094e+0 |
cdr2 | cerebellar degeneration-related 2 | 4.003e-3 | -2.106e+0 |
atp7a | ATPase, Cu++ transporting, alpha polypeptide | 1.404e-4 | -2.106e+0 |
lrp1 | low density lipoprotein receptor-related protein 1 | 2.477e-2 | -2.108e+0 |
btg1 | B-cell translocation gene 1, anti-proliferative | 6.515e-4 | -2.109e+0 |
c430042m11rik | RIKEN cDNA C430042M11 gene | 8.564e-5 | -2.111e+0 |
entpd1 | ectonucleoside triphosphate diphosphohydrolase 1 | 1.137e-3 | -2.112e+0 |
zfp236 | zinc finger protein 236 | 3.359e-4 | -2.113e+0 |
sdc1 | syndecan 1 | 7.065e-3 | -2.115e+0 |
ctsg | cathepsin G | 1.130e-2 | -2.117e+0 |
hopx | HOP homeobox | 2.283e-3 | -2.118e+0 |
cd24a | CD24a antigen | 3.020e-6 | -2.127e+0 |
plcl2 | phospholipase C-like 2 | 2.053e-4 | -2.130e+0 |
dock9 | dedicator of cytokinesis 9 | 9.078e-4 | -2.134e+0 |
sfrp2 | secreted frizzled-related protein 2 | 2.010e-3 | -2.134e+0 |
2610528a11rik | RIKEN cDNA 2610528A11 gene | 7.789e-5 | -2.135e+0 |
tubb2a | tubulin, beta 2a | 9.075e-5 | -2.137e+0 |
foxa1 | forkhead box A1 | 1.362e-3 | -2.138e+0 |
loc100047360 | similar to sex comb on midleg-like 2 (Drosophila) | 1.118e-2 | -2.140e+0 |
bcl3 | B-cell leukemia/lymphoma 3 | 1.743e-3 | -2.147e+0 |
cd97 | CD97 antigen | 1.179e-4 | -2.147e+0 |
skil | SKI-like | 6.448e-5 | -2.149e+0 |
sh3kbp1 | SH3-domain kinase binding protein 1 | 1.013e-5 | -2.150e+0 |
btg2 | B-cell translocation gene 2, anti-proliferative | 2.609e-3 | -2.151e+0 |
anxa2 | annexin A2 | 6.363e-4 | -2.153e+0 |
6720422m22rik | RIKEN cDNA 6720422M22 gene | 3.332e-3 | -2.156e+0 |
hist3h2a | histone cluster 3, H2a | 2.895e-4 | -2.157e+0 |
cnn3 | calponin 3, acidic | 3.826e-5 | -2.162e+0 |
fos | FBJ osteosarcoma oncogene | 3.257e-2 | -2.163e+0 |
slfn8 | schlafen 8 | 4.390e-2 | -2.168e+0 |
homer2 | homer homolog 2 (Drosophila) | 2.991e-3 | -2.170e+0 |
gpr137b-ps | G protein-coupled receptor 137B, pseudogene | 3.741e-3 | -2.172e+0 |
tox | thymocyte selection-associated high mobility group box | 4.075e-4 | -2.173e+0 |
niban | niban protein | 8.126e-4 | -2.173e+0 |
mboat1 | membrane bound O-acyltransferase domain containing 1 | 2.087e-3 | -2.176e+0 |
gadd45b | growth arrest and DNA-damage-inducible 45 beta | 3.944e-3 | -2.176e+0 |
ifi44 | interferon-induced protein 44 | 4.124e-2 | -2.179e+0 |
fcgr3 | Fc receptor, IgG, low affinity III | 7.042e-3 | -2.180e+0 |
serinc3 | serine incorporator 3 | 4.727e-6 | -2.182e+0 |
cfp | complement factor properdin | 9.788e-3 | -2.182e+0 |
slc18a2 | solute carrier family 18 (vesicular monoamine), member 2 | 4.487e-5 | -2.184e+0 |
tor1aip2 | torsin A interacting protein 2 | 1.090e-4 | -2.184e+0 |
aqp1 | aquaporin 1 | 6.571e-4 | -2.191e+0 |
gsdmd | gasdermin D | 4.823e-4 | -2.193e+0 |
chsy1 | chondroitin sulfate synthase 1 | 1.403e-5 | -2.193e+0 |
klf7 | Kruppel-like factor 7 (ubiquitous) | 8.895e-4 | -2.194e+0 |
d18ertd232e | DNA segment, Chr 18, ERATO Doi 232, expressed | 1.136e-2 | -2.194e+0 |
zc3h4 | zinc finger CCCH-type containing 4 | 4.034e-4 | -2.198e+0 |
itgb5 | integrin beta 5 | 3.740e-2 | -2.200e+0 |
rps6ka1 | ribosomal protein S6 kinase polypeptide 1 | 9.063e-7 | -2.201e+0 |
jag1 | jagged 1 | 1.324e-2 | -2.204e+0 |
rhoq | ras homolog gene family, member Q | 1.478e-4 | -2.204e+0 |
marveld2 | MARVEL (membrane-associating) domain containing 2 | 5.246e-4 | -2.205e+0 |
rab11fip5 | RAB11 family interacting protein 5 (class I) | 5.907e-3 | -2.220e+0 |
zdbf2 | zinc finger, DBF-type containing 2 | 1.919e-3 | -2.221e+0 |
prkd1 | protein kinase D1 | 1.427e-3 | -2.227e+0 |
axud1 | AXIN1 up-regulated 1 | 2.476e-3 | -2.228e+0 |
2610019f03rik | RIKEN cDNA 2610019F03 gene | 6.621e-4 | -2.231e+0 |
alox5 | arachidonate 5-lipoxygenase | 7.243e-4 | -2.235e+0 |
bc005512 | cDNA sequence BC005512 | 1.102e-4 | -2.238e+0 |
spag1 | sperm associated antigen 1 | 3.234e-3 | -2.241e+0 |
emr4 | EGF-like module containing, mucin-like, hormone receptor-like sequence 4 | 3.480e-2 | -2.244e+0 |
bc035044 | cDNA sequence BC035044 | 1.330e-3 | -2.254e+0 |
5230400m03rik | RIKEN cDNA 5230400M03 gene | 7.767e-4 | -2.257e+0 |
4632428n05rik | RIKEN cDNA 4632428N05 gene | 3.227e-3 | -2.260e+0 |
9030619p08rik | RIKEN cDNA 9030619P08 gene | 4.152e-3 | -2.261e+0 |
klf11 | Kruppel-like factor 11 | 7.917e-5 | -2.261e+0 |
steap4 | STEAP family member 4 | 7.791e-4 | -2.262e+0 |
dusp22 | dual specificity phosphatase 22 | 1.129e-3 | -2.263e+0 |
vill | villin-like | 1.809e-4 | -2.266e+0 |
hnmt | histamine N-methyltransferase | 1.628e-2 | -2.267e+0 |
b3galtl | beta 1,3-galactosyltransferase-like | 8.616e-5 | -2.272e+0 |
npepl1 | aminopeptidase-like 1 | 7.842e-5 | -2.273e+0 |
six6os1 | Six6 opposite strand transcript 1 | 1.947e-3 | -2.279e+0 |
pdgfb | platelet derived growth factor, B polypeptide | 3.478e-5 | -2.281e+0 |
selplg | selectin, platelet (p-selectin) ligand | 7.465e-5 | -2.284e+0 |
rhou | ras homolog gene family, member U | 3.220e-2 | -2.286e+0 |
fndc3b | fibronectin type III domain containing 3B | 2.500e-2 | -2.287e+0 |
tsix | X (inactive)-specific transcript, antisense | 1.803e-5 | -2.288e+0 |
3110043o21rik | RIKEN cDNA 3110043O21 gene | 5.996e-3 | -2.289e+0 |
dhdh | dihydrodiol dehydrogenase (dimeric) | 1.005e-3 | -2.290e+0 |
9430027b09rik | RIKEN cDNA 9430027B09 gene | 3.588e-4 | -2.292e+0 |
myh10 | myosin, heavy polypeptide 10, non-muscle | 3.447e-4 | -2.292e+0 |
hist1h1c | histone cluster 1, H1c | 7.236e-4 | -2.294e+0 |
olfm1 | olfactomedin 1 | 1.741e-3 | -2.299e+0 |
qpct | glutaminyl-peptide cyclotransferase (glutaminyl cyclase) | 4.335e-2 | -2.301e+0 |
1700006j14rik | RIKEN cDNA 1700006J14 gene | 2.050e-3 | -2.303e+0 |
rnf19b | ring finger protein 19B | 3.348e-3 | -2.303e+0 |
slc45a3 | solute carrier family 45, member 3 | 2.314e-4 | -2.305e+0 |
lmna | lamin A | 1.316e-6 | -2.309e+0 |
met | met proto-oncogene | 5.850e-3 | -2.316e+0 |
pmepa1 | prostate transmembrane protein, androgen induced 1 | 5.029e-4 | -2.318e+0 |
ets2 | E26 avian leukemia oncogene 2, 3' domain | 3.788e-5 | -2.331e+0 |
pcbd1 | pterin 4 alpha carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 1 | 4.661e-5 | -2.331e+0 |
atp8b4 | ATPase, class I, type 8B, member 4 | 8.228e-3 | -2.338e+0 |
gem | GTP binding protein (gene overexpressed in skeletal muscle) | 1.229e-2 | -2.339e+0 |
rrbp1 | ribosome binding protein 1 | 5.057e-4 | -2.341e+0 |
cd99 | CD99 antigen | 6.311e-4 | -2.344e+0 |
ottmusg00000011065 | predicted gene, OTTMUSG00000011065 | 4.213e-4 | -2.359e+0 |
hivep1 | human immunodeficiency virus type I enhancer binding protein 1 | 1.084e-4 | -2.362e+0 |
lpxn | leupaxin | 4.072e-2 | -2.363e+0 |
myadm | myeloid-associated differentiation marker | 1.674e-5 | -2.366e+0 |
nkg7 | natural killer cell group 7 sequence | 9.566e-4 | -2.369e+0 |
epha2 | Eph receptor A2 | 4.291e-4 | -2.371e+0 |
coq10b | coenzyme Q10 homolog B (S. cerevisiae) | 4.678e-4 | -2.377e+0 |
x99384 | cDNA sequence X99384 | 7.695e-4 | -2.382e+0 |
nedd9 | neural precursor cell expressed, developmentally down-regulated gene 9 | 3.935e-5 | -2.382e+0 |
2610027h17rik | RIKEN cDNA 2610027H17 gene | 5.755e-3 | -2.383e+0 |
cav2 | caveolin 2 | 1.259e-4 | -2.383e+0 |
trim6 | tripartite motif-containing 6 | 3.692e-4 | -2.389e+0 |
lpcat2 | lysophosphatidylcholine acyltransferase 2 | 9.367e-4 | -2.393e+0 |
cd33 | CD33 antigen | 2.649e-3 | -2.397e+0 |
app | amyloid beta (A4) precursor protein | 1.262e-3 | -2.399e+0 |
satb1 | special AT-rich sequence binding protein 1 | 9.429e-5 | -2.400e+0 |
af251705 | cDNA sequence AF251705 | 4.021e-2 | -2.401e+0 |
pik3r5 | phosphoinositide-3-kinase, regulatory subunit 5, p101 | 6.566e-3 | -2.404e+0 |
phactr2 | phosphatase and actin regulator 2 | 1.165e-4 | -2.407e+0 |
reck | reversion-inducing-cysteine-rich protein with kazal motifs | 2.966e-4 | -2.408e+0 |
rnase6 | ribonuclease, RNase A family, 6 | 4.136e-3 | -2.417e+0 |
arrdc3 | arrestin domain containing 3 | 2.862e-4 | -2.419e+0 |
fkbp9 | FK506 binding protein 9 | 1.774e-3 | -2.419e+0 |
fscn1 | fascin homolog 1, actin bundling protein (Strongylocentrotus purpuratus) | 5.087e-6 | -2.423e+0 |
apobec2 | apolipoprotein B mRNA editing enzyme, catalytic polypeptide 2 | 6.406e-4 | -2.426e+0 |
hbegf | heparin-binding EGF-like growth factor | 1.752e-3 | -2.432e+0 |
tmem51 | transmembrane protein 51 | 4.015e-3 | -2.439e+0 |
mns1 | meiosis-specific nuclear structural protein 1 | 3.651e-4 | -2.442e+0 |
loc100048050 | similar to calcium-independent alpha-latrotoxin receptor homolog 2 | 7.209e-5 | -2.442e+0 |
rhob | ras homolog gene family, member B | 7.313e-4 | -2.448e+0 |
fosl2 | fos-like antigen 2 | 3.072e-4 | -2.449e+0 |
camk1 | calcium/calmodulin-dependent protein kinase I | 9.794e-4 | -2.452e+0 |
ly6a | lymphocyte antigen 6 complex, locus A | 3.500e-2 | -2.477e+0 |
glipr1 | GLI pathogenesis-related 1 (glioma) | 1.765e-4 | -2.480e+0 |
zfp36 | zinc finger protein 36 | 2.259e-3 | -2.481e+0 |
arl4c | ADP-ribosylation factor-like 4C | 3.063e-4 | -2.486e+0 |
ifrd1 | interferon-related developmental regulator 1 | 1.224e-3 | -2.487e+0 |
cdc14b | CDC14 cell division cycle 14 homolog B (S. cerevisiae) | 2.954e-4 | -2.487e+0 |
cd300a | CD300A antigen | 8.043e-5 | -2.490e+0 |
a230106d06rik | RIKEN cDNA A230106D06 gene | 9.072e-4 | -2.496e+0 |
mansc1 | MANSC domain containing 1 | 3.229e-4 | -2.496e+0 |
bc022623 | cDNA sequence BC022623 | 4.860e-6 | -2.504e+0 |
zfp516 | zinc finger protein 516 | 5.455e-6 | -2.510e+0 |
s100a11 | S100 calcium binding protein A11 (calgizzarin) | 3.372e-6 | -2.510e+0 |
bcl6 | B-cell leukemia/lymphoma 6 | 2.254e-4 | -2.519e+0 |
jup | junction plakoglobin | 2.605e-3 | -2.520e+0 |
adamts1 | a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 | 1.193e-2 | -2.530e+0 |
rhoc | ras homolog gene family, member C | 4.493e-3 | -2.539e+0 |
apoc1 | apolipoprotein C-I | 1.305e-3 | -2.540e+0 |
uaca | uveal autoantigen with coiled-coil domains and ankyrin repeats | 1.570e-3 | -2.543e+0 |
loc552908 | hypothetical LOC552908 | 3.350e-3 | -2.544e+0 |
map3k8 | mitogen-activated protein kinase kinase kinase 8 | 3.136e-3 | -2.544e+0 |
errfi1 | ERBB receptor feedback inhibitor 1 | 1.589e-2 | -2.551e+0 |
mum1l1 | melanoma associated antigen (mutated) 1-like 1 | 6.316e-4 | -2.555e+0 |
zscan18 | zinc finger and SCAN domain containing 18 | 3.186e-3 | -2.561e+0 |
gch1 | GTP cyclohydrolase 1 | 2.018e-3 | -2.564e+0 |
pkig | protein kinase inhibitor, gamma | 8.641e-6 | -2.569e+0 |
rcn3 | reticulocalbin 3, EF-hand calcium binding domain | 4.904e-4 | -2.571e+0 |
nlrp3 | NLR family, pyrin domain containing 3 | 1.802e-2 | -2.572e+0 |
ptprc | protein tyrosine phosphatase, receptor type, C | 6.751e-4 | -2.574e+0 |
irf6 | interferon regulatory factor 6 | 1.587e-3 | -2.578e+0 |
adrb2 | adrenergic receptor, beta 2 | 1.157e-3 | -2.585e+0 |
4930431b09rik | RIKEN cDNA 4930431B09 gene | 1.942e-2 | -2.585e+0 |
camk1d | calcium/calmodulin-dependent protein kinase ID | 3.125e-4 | -2.588e+0 |
ai426953 | expressed sequence AI426953 | 1.114e-3 | -2.602e+0 |
ncf2 | neutrophil cytosolic factor 2 | 3.653e-4 | -2.604e+0 |
dusp16 | dual specificity phosphatase 16 | 1.920e-5 | -2.607e+0 |
s1pr1 | sphingosine-1-phosphate receptor 1 | 1.875e-5 | -2.615e+0 |
pira6 | paired-Ig-like receptor A6 | 6.069e-3 | -2.622e+0 |
agpat9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | 3.507e-2 | -2.623e+0 |
2610305j24rik | RIKEN cDNA 2610305J24 gene | 1.783e-3 | -2.627e+0 |
pdlim4 | PDZ and LIM domain 4 | 6.189e-3 | -2.627e+0 |
evi1 | ecotropic viral integration site 1 | 2.819e-5 | -2.628e+0 |
itgax | integrin alpha X | 3.646e-2 | -2.635e+0 |
akap12 | A kinase (PRKA) anchor protein (gravin) 12 | 1.376e-2 | -2.638e+0 |
gpx3 | glutathione peroxidase 3 | 4.564e-3 | -2.643e+0 |
c030046g05 | hypothetical protein C030046G05 | 8.509e-5 | -2.643e+0 |
ai747699 | expressed sequence AI747699 | 9.904e-7 | -2.645e+0 |
ptger4 | prostaglandin E receptor 4 (subtype EP4) | 7.432e-3 | -2.649e+0 |
1200016e24rik | RIKEN cDNA 1200016E24 gene | 1.496e-3 | -2.652e+0 |
d730035f11rik | RIKEN cDNA D730035F11 gene | 1.308e-3 | -2.655e+0 |
2310014d11rik | RIKEN cDNA 2310014D11 gene | 2.209e-3 | -2.657e+0 |
rapgef2 | Rap guanine nucleotide exchange factor (GEF) 2 | 1.820e-4 | -2.661e+0 |
cd69 | CD69 antigen | 2.178e-3 | -2.669e+0 |
3830612m24 | hypothetical protein 3830612M24 | 1.143e-4 | -2.672e+0 |
gm2a | GM2 ganglioside activator protein | 1.382e-3 | -2.674e+0 |
acp5 | acid phosphatase 5, tartrate resistant | 4.265e-3 | -2.676e+0 |
raph1 | Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 | 3.522e-4 | -2.677e+0 |
cxcr7 | chemokine (C-X-C motif) receptor 7 | 1.162e-2 | -2.687e+0 |
9530006c21rik | RIKEN cDNA 9530006C21 gene | 1.662e-4 | -2.690e+0 |
sgk3 | serum/glucocorticoid regulated kinase 3 | 1.632e-4 | -2.695e+0 |
dab2 | disabled homolog 2 (Drosophila) | 2.207e-2 | -2.701e+0 |
adrbk2 | adrenergic receptor kinase, beta 2 | 8.193e-5 | -2.709e+0 |
hpse | heparanase | 3.432e-3 | -2.724e+0 |
thbd | thrombomodulin | 1.942e-3 | -2.730e+0 |
rps4y2 | ribosomal protein S4, Y-linked 2 | 1.284e-3 | -2.731e+0 |
vasn | vasorin | 1.928e-6 | -2.733e+0 |
tnfaip3 | tumor necrosis factor, alpha-induced protein 3 | 2.434e-3 | -2.735e+0 |
gimap8 | GTPase, IMAP family member 8 | 3.006e-3 | -2.743e+0 |
9130404d14rik | RIKEN cDNA 9130404D14 gene | 1.512e-5 | -2.759e+0 |
glis3 | GLIS family zinc finger 3 | 2.782e-3 | -2.760e+0 |
zfp105 | zinc finger protein 105 | 7.939e-4 | -2.764e+0 |
2210016f16rik | RIKEN cDNA 2210016F16 gene | 6.702e-5 | -2.769e+0 |
cd300lb | CD300 antigen like family member B | 1.494e-2 | -2.772e+0 |
nfkbid | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta | 5.942e-4 | -2.778e+0 |
p2ry14 | purinergic receptor P2Y, G-protein coupled, 14 | 7.765e-3 | -2.778e+0 |
hrasls3 | HRAS like suppressor 3 | 6.083e-4 | -2.779e+0 |
mreg | melanoregulin | 1.353e-3 | -2.780e+0 |
plagl1 | pleiomorphic adenoma gene-like 1 | 2.135e-3 | -2.780e+0 |
c1qdc2 | C1q domain containing 2 | 7.706e-7 | -2.784e+0 |
cd300lf | CD300 antigen like family member F | 3.008e-2 | -2.787e+0 |
ncf1 | neutrophil cytosolic factor 1 | 1.251e-3 | -2.790e+0 |
lincr | lung-inducible neuralized-related C3HC4 RING domain protein | 4.029e-3 | -2.792e+0 |
loc100046855 | similar to BKLF | 6.487e-9 | -2.792e+0 |
mpo | myeloperoxidase | 3.663e-5 | -2.799e+0 |
lonrf3 | LON peptidase N-terminal domain and ring finger 3 | 3.556e-4 | -2.813e+0 |
dusp4 | dual specificity phosphatase 4 | 1.916e-4 | -2.813e+0 |
tmem88 | transmembrane protein 88 | 3.570e-5 | -2.819e+0 |
rel | reticuloendotheliosis oncogene | 1.687e-4 | -2.821e+0 |
gpc4 | glypican 4 | 1.084e-3 | -2.825e+0 |
cobll1 | Cobl-like 1 | 4.362e-4 | -2.833e+0 |
rgs16 | regulator of G-protein signaling 16 | 1.031e-4 | -2.838e+0 |
myo7a | myosin VIIa | 2.233e-5 | -2.838e+0 |
tiparp | TCDD-inducible poly(ADP-ribose) polymerase | 9.003e-4 | -2.850e+0 |
cotl1 | coactosin-like 1 (Dictyostelium) | 3.676e-5 | -2.853e+0 |
fyb | FYN binding protein | 1.552e-3 | -2.862e+0 |
id2 | inhibitor of DNA binding 2 | 6.243e-3 | -2.867e+0 |
1700097n02rik | RIKEN cDNA 1700097N02 gene | 9.297e-5 | -2.871e+0 |
ai662270 | expressed sequence AI662270 | 2.306e-4 | -2.875e+0 |
f13a1 | coagulation factor XIII, A1 subunit | 6.850e-3 | -2.877e+0 |
rasgrp3 | RAS, guanyl releasing protein 3 | 7.584e-5 | -2.884e+0 |
nfkbie | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 2.096e-4 | -2.885e+0 |
parp8 | poly (ADP-ribose) polymerase family, member 8 | 1.188e-4 | -2.886e+0 |
pld4 | phospholipase D family, member 4 | 2.854e-3 | -2.891e+0 |
egr3 | early growth response 3 | 3.418e-7 | -2.902e+0 |
gimap6 | GTPase, IMAP family member 6 | 2.285e-4 | -2.902e+0 |
tpm2 | tropomyosin 2, beta | 9.140e-6 | -2.904e+0 |
relb | avian reticuloendotheliosis viral (v-rel) oncogene related B | 1.992e-4 | -2.907e+0 |
tacc2 | transforming, acidic coiled-coil containing protein 2 | 3.110e-4 | -2.918e+0 |
a630077b13rik | RIKEN cDNA A630077B13 gene | 6.525e-3 | -2.925e+0 |
hist1h2bc | histone cluster 1, H2bc | 1.433e-5 | -2.929e+0 |
tcfec | transcription factor EC | 1.157e-2 | -2.939e+0 |
pstpip2 | proline-serine-threonine phosphatase-interacting protein 2 | 1.503e-3 | -2.940e+0 |
jun | Jun oncogene | 1.440e-5 | -2.942e+0 |
tgif1 | TGFB-induced factor homeobox 1 | 1.374e-3 | -2.943e+0 |
fgd5 | FYVE, RhoGEF and PH domain containing 5 | 1.011e-3 | -2.945e+0 |
rrad | Ras-related associated with diabetes | 1.387e-5 | -2.961e+0 |
mn1 | meningioma 1 | 6.213e-4 | -2.968e+0 |
rnase4 | ribonuclease, RNase A family 4 | 3.925e-3 | -2.976e+0 |
fhod3 | formin homology 2 domain containing 3 | 1.522e-3 | -2.985e+0 |
klhl13 | kelch-like 13 (Drosophila) | 1.614e-2 | -2.991e+0 |
eps8 | epidermal growth factor receptor pathway substrate 8 | 6.329e-3 | -2.993e+0 |
hprt1 | hypoxanthine guanine phosphoribosyl transferase 1 | 1.642e-6 | -3.006e+0 |
ramp3 | receptor (calcitonin) activity modifying protein 3 | 1.205e-4 | -3.010e+0 |
rpl39l | ribosomal protein L39-like | 3.283e-4 | -3.012e+0 |
crip1 | cysteine-rich protein 1 (intestinal) | 2.514e-4 | -3.016e+0 |
plaur | plasminogen activator, urokinase receptor | 7.312e-4 | -3.024e+0 |
kcnk6 | potassium inwardly-rectifying channel, subfamily K, member 6 | 1.937e-4 | -3.026e+0 |
mdk | midkine | 2.620e-4 | -3.028e+0 |
pdk4 | pyruvate dehydrogenase kinase, isoenzyme 4 | 9.612e-7 | -3.032e+0 |
ccnd1 | cyclin D1 | 3.597e-9 | -3.044e+0 |
bzrap1 | benzodiazapine receptor associated protein 1 | 4.218e-3 | -3.058e+0 |
slc38a4 | solute carrier family 38, member 4 | 4.020e-2 | -3.061e+0 |
4930506m07rik | RIKEN cDNA 4930506M07 gene | 3.018e-2 | -3.066e+0 |
wdr40b | WD repeat domain 40B | 6.720e-3 | -3.074e+0 |
b3galnt1 | UDP-GalNAc:betaGlcNAc beta 1,3-galactosaminyltransferase, polypeptide 1 | 9.920e-3 | -3.075e+0 |
loc100047856 | similar to calponin 3, acidic | 2.686e-5 | -3.077e+0 |
ly9 | lymphocyte antigen 9 | 3.648e-3 | -3.086e+0 |
cebpb | CCAAT/enhancer binding protein (C/EBP), beta | 2.760e-4 | -3.088e+0 |
s100a6 | S100 calcium binding protein A6 (calcyclin) | 8.875e-3 | -3.089e+0 |
irak2 | interleukin-1 receptor-associated kinase 2 | 4.055e-4 | -3.091e+0 |
bank1 | B-cell scaffold protein with ankyrin repeats 1 | 8.943e-4 | -3.114e+0 |
dusp1 | dual specificity phosphatase 1 | 1.797e-3 | -3.115e+0 |
nfkbia | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 4.270e-5 | -3.127e+0 |
1810015c04rik | RIKEN cDNA 1810015C04 gene | 4.559e-5 | -3.136e+0 |
chd7 | chromodomain helicase DNA binding protein 7 | 1.107e-4 | -3.146e+0 |
c330011k17rik | RIKEN cDNA C330011K17 gene | 4.073e-5 | -3.150e+0 |
4631422o05rik | RIKEN cDNA 4631422O05 gene | 7.307e-4 | -3.150e+0 |
igsf6 | immunoglobulin superfamily, member 6 | 4.755e-3 | -3.158e+0 |
bc013712 | cDNA sequence BC013712 | 2.482e-3 | -3.175e+0 |
btla | B and T lymphocyte associated | 7.250e-4 | -3.182e+0 |
spata5l1 | spermatogenesis associated 5-like 1 | 1.421e-7 | -3.183e+0 |
trem1 | triggering receptor expressed on myeloid cells 1 | 4.179e-3 | -3.191e+0 |
pla2g7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 4.423e-2 | -3.194e+0 |
gbp3 | guanylate binding protein 3 | 3.210e-4 | -3.196e+0 |
ckap4 | cytoskeleton-associated protein 4 | 2.632e-5 | -3.198e+0 |
cdh1 | cadherin 1 | 4.044e-2 | -3.208e+0 |
ccr7 | chemokine (C-C motif) receptor 7 | 1.962e-3 | -3.210e+0 |
rab20 | RAB20, member RAS oncogene family | 3.743e-2 | -3.214e+0 |
1100001h23rik | RIKEN cDNA 1100001H23 gene | 1.397e-2 | -3.214e+0 |
hist1h4i | histone cluster 1, H4i | 5.451e-5 | -3.216e+0 |
pygl | liver glycogen phosphorylase | 4.272e-6 | -3.220e+0 |
acot1 | acyl-CoA thioesterase 1 | 2.181e-5 | -3.239e+0 |
casp4 | caspase 4, apoptosis-related cysteine peptidase | 5.039e-4 | -3.250e+0 |
hoxa9 | homeo box A9 | 4.386e-5 | -3.263e+0 |
slc28a2 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 | 2.721e-3 | -3.283e+0 |
gimap4 | GTPase, IMAP family member 4 | 1.623e-6 | -3.287e+0 |
cdh17 | cadherin 17 | 1.918e-4 | -3.288e+0 |
phlda1 | pleckstrin homology-like domain, family A, member 1 | 2.968e-7 | -3.302e+0 |
0610037m15rik | RIKEN cDNA 0610037M15 gene | 2.118e-2 | -3.306e+0 |
klf6 | Kruppel-like factor 6 | 9.838e-5 | -3.310e+0 |
ecm1 | extracellular matrix protein 1 | 8.101e-4 | -3.314e+0 |
gja1 | gap junction protein, alpha 1 | 1.127e-4 | -3.322e+0 |
bmp2 | bone morphogenetic protein 2 | 3.314e-5 | -3.332e+0 |
tek | endothelial-specific receptor tyrosine kinase | 7.608e-4 | -3.332e+0 |
cd79b | CD79B antigen | 2.219e-5 | -3.341e+0 |
flt3 | FMS-like tyrosine kinase 3 | 1.793e-4 | -3.351e+0 |
stfa1 | stefin A1 | 1.201e-2 | -3.357e+0 |
oasl2 | 2'-5' oligoadenylate synthetase-like 2 | 1.241e-2 | -3.368e+0 |
1110067d22rik | RIKEN cDNA 1110067D22 gene | 1.551e-3 | -3.370e+0 |
rnf125 | ring finger protein 125 | 1.228e-6 | -3.378e+0 |
emcn | endomucin | 1.634e-3 | -3.412e+0 |
arg2 | arginase type II | 4.532e-2 | -3.441e+0 |
bex1 | brain expressed gene 1 | 4.282e-5 | -3.445e+0 |
tnfrsf13c | tumor necrosis factor receptor superfamily, member 13c | 2.710e-5 | -3.452e+0 |
tgm2 | transglutaminase 2, C polypeptide | 6.352e-4 | -3.460e+0 |
trap1a | tumor rejection antigen P1A | 2.689e-2 | -3.471e+0 |
areg | amphiregulin | 2.596e-2 | -3.473e+0 |
slc15a3 | solute carrier family 15, member 3 | 1.418e-2 | -3.482e+0 |
rsad2 | radical S-adenosyl methionine domain containing 2 | 1.604e-2 | -3.495e+0 |
dse | dermatan sulfate epimerase | 1.871e-3 | -3.506e+0 |
irf8 | interferon regulatory factor 8 | 8.851e-5 | -3.520e+0 |
9830134c10rik | RIKEN cDNA 9830134C10 gene | 5.224e-4 | -3.541e+0 |
g0s2 | G0/G1 switch gene 2 | 4.249e-3 | -3.545e+0 |
prtn3 | proteinase 3 | 2.278e-5 | -3.546e+0 |
1110032e23rik | RIKEN cDNA 1110032E23 gene | 7.397e-5 | -3.576e+0 |
csf3r | colony stimulating factor 3 receptor (granulocyte) | 4.787e-5 | -3.577e+0 |
antxr2 | anthrax toxin receptor 2 | 3.550e-6 | -3.593e+0 |
krt8 | keratin 8 | 2.089e-2 | -3.614e+0 |
1200002n14rik | RIKEN cDNA 1200002N14 gene | 1.591e-3 | -3.616e+0 |
dlk1 | delta-like 1 homolog (Drosophila) | 2.785e-4 | -3.625e+0 |
mdfic | MyoD family inhibitor domain containing | 8.548e-3 | -3.626e+0 |
fosb | FBJ osteosarcoma oncogene B | 2.173e-3 | -3.635e+0 |
loc73899 | hypothetical LOC73899 | 1.201e-4 | -3.635e+0 |
loc100045217 | similar to Transmembrane protein with EGF-like and two follistatin-like domains 1 | 1.452e-4 | -3.641e+0 |
dusp6 | dual specificity phosphatase 6 | 6.733e-5 | -3.641e+0 |
pira1 | paired-Ig-like receptor A1 | 7.991e-5 | -3.645e+0 |
cd68 | CD68 antigen | 2.006e-2 | -3.655e+0 |
cybb | cytochrome b-245, beta polypeptide | 1.095e-2 | -3.673e+0 |
xlr3a | X-linked lymphocyte-regulated 3A | 5.931e-5 | -3.682e+0 |
nfil3 | nuclear factor, interleukin 3, regulated | 4.939e-4 | -3.684e+0 |
cd36 | CD36 antigen | 2.151e-2 | -3.685e+0 |
slc16a7 | solute carrier family 16 (monocarboxylic acid transporters), member 7 | 2.900e-4 | -3.685e+0 |
s100a9 | S100 calcium binding protein A9 (calgranulin B) | 3.067e-2 | -3.687e+0 |
ccrl2 | chemokine (C-C motif) receptor-like 2 | 1.218e-2 | -3.706e+0 |
fn1 | fibronectin 1 | 6.755e-4 | -3.707e+0 |
tnf | tumor necrosis factor | 1.009e-2 | -3.718e+0 |
osm | oncostatin M | 1.306e-2 | -3.725e+0 |
klrd1 | killer cell lectin-like receptor, subfamily D, member 1 | 1.891e-6 | -3.741e+0 |
rbpms | RNA binding protein gene with multiple splicing | 4.486e-8 | -3.741e+0 |
il1a | interleukin 1 alpha | 2.504e-2 | -3.752e+0 |
ltb | lymphotoxin B | 2.770e-6 | -3.779e+0 |
csf1r | colony stimulating factor 1 receptor | 2.315e-4 | -3.779e+0 |
cd86 | CD86 antigen | 1.376e-3 | -3.809e+0 |
marcks | myristoylated alanine rich protein kinase C substrate | 2.366e-6 | -3.810e+0 |
sdc4 | syndecan 4 | 9.252e-3 | -3.813e+0 |
maff | v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) | 1.473e-4 | -3.831e+0 |
nuak2 | NUAK family, SNF1-like kinase, 2 | 6.388e-5 | -3.841e+0 |
klf2 | Kruppel-like factor 2 (lung) | 1.648e-4 | -3.844e+0 |
postn | periostin, osteoblast specific factor | 2.222e-4 | -3.845e+0 |
slc11a1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 2.107e-2 | -3.861e+0 |
5133401h06rik | RIKEN cDNA 5133401H06 gene | 4.562e-3 | -3.873e+0 |
speer1-ps1 | spermatogenesis associated glutamate (E)-rich protein 1, pseudogene 1 | 9.736e-4 | -3.875e+0 |
cd27 | CD27 antigen | 5.986e-5 | -3.879e+0 |
capn2 | calpain 2 | 5.771e-5 | -3.881e+0 |
ms4a6c | membrane-spanning 4-domains, subfamily A, member 6C | 1.843e-2 | -3.881e+0 |
cd74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | 1.099e-2 | -3.893e+0 |
socs3 | suppressor of cytokine signaling 3 | 6.349e-3 | -3.907e+0 |
gzmd | granzyme D | 2.075e-2 | -3.942e+0 |
ddx4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 2.571e-4 | -3.963e+0 |
fmnl2 | formin-like 2 | 1.255e-4 | -3.964e+0 |
cxcl1 | chemokine (C-X-C motif) ligand 1 | 2.499e-2 | -3.966e+0 |
col4a1 | collagen, type IV, alpha 1 | 1.406e-2 | -4.007e+0 |
nr4a1 | nuclear receptor subfamily 4, group A, member 1 | 2.146e-5 | -4.029e+0 |
mpeg1 | macrophage expressed gene 1 | 1.155e-2 | -4.033e+0 |
ampd3 | adenosine monophosphate deaminase 3 | 1.299e-5 | -4.041e+0 |
ocln | occludin | 6.362e-5 | -4.065e+0 |
igf2bp1 | insulin-like growth factor 2 mRNA binding protein 1 | 8.935e-7 | -4.071e+0 |
ccl4 | chemokine (C-C motif) ligand 4 | 4.968e-3 | -4.076e+0 |
oaf | OAF homolog (Drosophila) | 7.094e-6 | -4.109e+0 |
prdm1 | PR domain containing 1, with ZNF domain | 1.366e-4 | -4.128e+0 |
egr2 | early growth response 2 | 7.487e-3 | -4.131e+0 |
gpr84 | G protein-coupled receptor 84 | 3.965e-5 | -4.159e+0 |
snx24 | sorting nexing 24 | 3.218e-5 | -4.168e+0 |
pyhin1 | pyrin and HIN domain family, member 1 | 1.186e-2 | -4.176e+0 |
cd302 | CD302 antigen | 2.407e-5 | -4.180e+0 |
tyrobp | TYRO protein tyrosine kinase binding protein | 4.260e-5 | -4.203e+0 |
evi5 | ecotropic viral integration site 5 | 4.289e-5 | -4.206e+0 |
eg622976 | predicted gene, EG622976 | 3.927e-2 | -4.215e+0 |
ear2 | eosinophil-associated, ribonuclease A family, member 2 | 2.747e-2 | -4.233e+0 |
pmaip1 | phorbol-12-myristate-13-acetate-induced protein 1 | 4.955e-5 | -4.248e+0 |
kcnn4 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 | 6.079e-7 | -4.252e+0 |
trf | transferrin | 5.859e-5 | -4.254e+0 |
cd14 | CD14 antigen | 2.094e-2 | -4.279e+0 |
adam8 | a disintegrin and metallopeptidase domain 8 | 3.432e-3 | -4.299e+0 |
c730049o14rik | RIKEN cDNA C730049O14 gene | 3.006e-6 | -4.329e+0 |
c1qb | complement component 1, q subcomponent, beta polypeptide | 4.149e-2 | -4.331e+0 |
ai607873 | expressed sequence AI607873 | 2.266e-2 | -4.361e+0 |
ccl6 | chemokine (C-C motif) ligand 6 | 1.133e-2 | -4.367e+0 |
gatm | glycine amidinotransferase (L-arginine:glycine amidinotransferase) | 2.906e-4 | -4.368e+0 |
fstl1 | follistatin-like 1 | 3.079e-5 | -4.391e+0 |
dsp | desmoplakin | 5.600e-3 | -4.398e+0 |
pdpn | podoplanin | 1.885e-2 | -4.409e+0 |
tjp1 | tight junction protein 1 | 2.036e-3 | -4.421e+0 |
icam1 | intercellular adhesion molecule 1 | 7.414e-7 | -4.426e+0 |
hdc | histidine decarboxylase | 1.064e-5 | -4.434e+0 |
cdkn1c | cyclin-dependent kinase inhibitor 1C (P57) | 3.668e-3 | -4.434e+0 |
2610528g24rik | RIKEN cDNA 2610528G24 gene | 4.408e-6 | -4.439e+0 |
lgmn | legumain | 8.634e-3 | -4.456e+0 |
ankrd57 | ankyrin repeat domain 57 | 2.412e-3 | -4.463e+0 |
plac8 | placenta-specific 8 | 2.903e-4 | -4.470e+0 |
col4a2 | collagen, type IV, alpha 2 | 1.228e-2 | -4.488e+0 |
anxa3 | annexin A3 | 3.274e-5 | -4.489e+0 |
2210403k04rik | RIKEN cDNA 2210403K04 gene | 1.077e-5 | -4.494e+0 |
h2-aa | histocompatibility 2, class II antigen A, alpha | 2.216e-3 | -4.512e+0 |
traf1 | Tnf receptor-associated factor 1 | 1.647e-5 | -4.527e+0 |
nfkbiz | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 2.091e-6 | -4.536e+0 |
hck | hemopoietic cell kinase | 1.563e-3 | -4.546e+0 |
loc100044979 | similar to Gpr137b protein | 1.154e-4 | -4.551e+0 |
igf2bp2 | insulin-like growth factor 2 mRNA binding protein 2 | 2.396e-5 | -4.615e+0 |
h2-eb1 | histocompatibility 2, class II antigen E beta | 3.389e-3 | -4.651e+0 |
bhlhb2 | basic helix-loop-helix domain containing, class B2 | 3.152e-5 | -4.667e+0 |
ms4a4c | membrane-spanning 4-domains, subfamily A, member 4C | 2.085e-2 | -4.703e+0 |
loc215866 | hypothetical protein LOC215866 | 8.375e-7 | -4.707e+0 |
ly86 | lymphocyte antigen 86 | 5.043e-3 | -4.741e+0 |
eltd1 | EGF, latrophilin seven transmembrane domain containing 1 | 3.146e-6 | -4.744e+0 |
slc35d3 | solute carrier family 35, member D3 | 3.020e-4 | -4.789e+0 |
clec7a | C-type lectin domain family 7, member a | 6.981e-3 | -4.798e+0 |
tubb2b | tubulin, beta 2b | 6.188e-9 | -4.810e+0 |
lsp1 | lymphocyte specific 1 | 1.349e-7 | -4.813e+0 |
a130040m12rik | RIKEN cDNA A130040M12 gene | 6.799e-7 | -4.841e+0 |
il1r2 | interleukin 1 receptor, type II | 3.401e-6 | -4.854e+0 |
dusp5 | dual specificity phosphatase 5 | 8.882e-9 | -4.863e+0 |
ptgs2 | prostaglandin-endoperoxide synthase 2 | 4.701e-3 | -4.863e+0 |
il1b | interleukin 1 beta | 7.037e-3 | -4.867e+0 |
irg1 | immunoresponsive gene 1 | 2.043e-3 | -4.883e+0 |
xist | inactive X specific transcripts | 7.940e-6 | -4.896e+0 |
ctss | cathepsin S | 4.292e-3 | -4.897e+0 |
as3mt | arsenic (+3 oxidation state) methyltransferase | 2.910e-7 | -4.996e+0 |
ctsh | cathepsin H | 7.321e-3 | -5.009e+0 |
ms4a6b | membrane-spanning 4-domains, subfamily A, member 6B | 3.199e-3 | -5.029e+0 |
cd34 | CD34 antigen | 7.160e-6 | -5.146e+0 |
slfn4 | schlafen 4 | 7.633e-3 | -5.191e+0 |
ddx3y | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked | 2.950e-7 | -5.196e+0 |
aa467197 | expressed sequence AA467197 | 1.067e-3 | -5.197e+0 |
rgs1 | regulator of G-protein signaling 1 | 1.121e-4 | -5.200e+0 |
sgk1 | serum/glucocorticoid regulated kinase 1 | 4.381e-4 | -5.241e+0 |
atf3 | activating transcription factor 3 | 1.679e-4 | -5.359e+0 |
krt18 | keratin 18 | 4.522e-4 | -5.393e+0 |
cytip | cytohesin 1 interacting protein | 1.940e-6 | -5.405e+0 |
klf4 | Kruppel-like factor 4 (gut) | 7.325e-5 | -5.427e+0 |
ottmusg00000000971 | predicted gene, OTTMUSG00000000971 | 4.443e-4 | -5.475e+0 |
tgfbi | transforming growth factor, beta induced | 2.135e-3 | -5.552e+0 |
rmcs5 | response to metastatic cancers 5 | 7.843e-4 | -5.568e+0 |
plk2 | polo-like kinase 2 (Drosophila) | 5.268e-6 | -5.588e+0 |
cxcl3 | chemokine (C-X-C motif) ligand 3 | 5.709e-3 | -5.597e+0 |
chi3l3 | chitinase 3-like 3 | 8.323e-3 | -5.618e+0 |
olr1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 2.696e-4 | -5.639e+0 |
smpdl3a | sphingomyelin phosphodiesterase, acid-like 3A | 2.488e-5 | -6.091e+0 |
cxcl10 | chemokine (C-X-C motif) ligand 10 | 2.325e-5 | -6.191e+0 |
lgals3 | lectin, galactose binding, soluble 3 | 6.772e-4 | -6.439e+0 |
bcl2a1a | B-cell leukemia/lymphoma 2 related protein A1a | 1.902e-4 | -6.474e+0 |
hspa1a | heat shock protein 1A | 2.991e-6 | -6.520e+0 |
cd83 | CD83 antigen | 2.939e-5 | -6.595e+0 |
apoe | apolipoprotein E | 4.931e-6 | -6.786e+0 |
ccl3 | chemokine (C-C motif) ligand 3 | 1.976e-4 | -6.900e+0 |
h19 | H19 fetal liver mRNA | 3.086e-5 | -6.953e+0 |
hspa1b | heat shock protein 1B | 4.243e-8 | -7.193e+0 |
cxcl2 | chemokine (C-X-C motif) ligand 2 | 2.110e-5 | -8.449e+0 |